MOG 89 - 113, human

Myelin oligodendrocyte glycoprotein (MOG) 89 - 113, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is believed to be a target autoantigen in multiple sclerosis. MOG 89 - 113 peptide is an immunodominant epitope of MOG that induces strong T and B cell responses and Induces experimental autoimmune encephalomyelitis in rodents. A single injection of this peptide produces a relapsing-remitting neurologic disease with extensive plaque-like demyelination. This Cysteine containing MOG 89 - 113 peptide can be use to induced polyclonal anti-MOG 89 - 113 antibody production in rabbits with high specificity, high affinity, and high titer indicating its high purity, as well as suitability for peptide-coated ELISA and Western blot assay. Immunization with MOG 89 - 113 suppresses spontaneous regeneration of dopaminergic neurons injured with MPTP. Multiple Sclerosis: MOG 89 - 113 induced experimental autoimmune encephalomyelitis (EAE) rodent models

Protocols and Tips

• Handling peptides

Data sheets

• Safety data sheet poly peptides

• Material Data Sheet
• Safety Data Sheet

• Do you have any questions concerning this product?